Cart
sales@molnova.com
Phenylethyl isothiocyanate
CAS No. 2257-09-2
Phenylethyl isothiocyanate( JC-5411,JC5411,JC 5411 )
Catalog No. M22864 CAS No. 2257-09-2
Phenylethyl isothiocyanate is an HDAC inhibitor. It potentially for the treatment of benign prostatic hypertrophy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 38 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhenylethyl isothiocyanate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenylethyl isothiocyanate is an HDAC inhibitor. It potentially for the treatment of benign prostatic hypertrophy.
-
DescriptionPhenylethyl isothiocyanate is an HDAC inhibitor. It potentially for the treatment of benign prostatic hypertrophy.
-
In Vitro——
-
In Vivo——
-
SynonymsJC-5411,JC5411,JC 5411
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2257-09-2
-
Formula Weight163.23
-
Molecular FormulaC9H9NS
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESC1=CC=C(C=C1)CCN=C=S
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhu Y , Liu S , Yan S , et al. Phenylethyl isothiocyanate induces oxidative damage of porcine kidney cells mediated by reactive oxygen species[J]. Journal of Biochemical and Molecular Toxicology, 2020, 34(2).
molnova catalog
related products
-
TYA-018
TYA-018 is an orally available and selective HDAC6 inhibitor with cardioprotective properties for the study of dilated heart disease and heart failure.TYA-018 prevents sarcomere damage and decreases Nppb expression.
-
4SC-202 free base
4SC-202 is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively.
-
SIS17
SIS17 is a potent and selective HDAC 11 inhibitor with an IC50 value of 0.83 μM. SIS17 is active in cells and inhibited the demyristoylation of a known HDAC11 substrate serine hydroxymethyl transferase 2 without inhibiting other HDACs.
